Form 4: Leidos Holdings Executive Gerard A. Fasano Reports Stock Option Grant

Sentiment:

SEC Form 4 Filing


Chief Growth Officer Gerard A. Fasano of Leidos Holdings, Inc. reports the acquisition of stock options.

Summary

  • Gerard A. Fasano, Chief Growth Officer of Leidos Holdings, Inc., filed a Form 4 on March 12, 2024, reporting a transaction.
  • The transaction involved the acquisition of stock options (right to buy) at a price of $129.79 on March 8, 2024.
  • Fasano acquired 8,410 stock options, exercisable beginning March 8, 2025, and expiring on March 7, 2031.
  • The options vest in three annual installments starting March 8, 2025.
  • Following the reported transaction, Fasano directly owns 8,410 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard executive compensation practice. It's neither particularly positive nor negative from an investment perspective.

Positives

  • The grant of stock options to a key executive aligns their interests with those of the shareholders, incentivizing them to improve company performance.

Industry Context

Stock option grants are a common form of executive compensation in the technology and defense industries, used to incentivize performance and retain key talent.

Comparison to Industry Standards

  • Stock option grants are a standard component of executive compensation packages in publicly traded companies, particularly in the tech and defense sectors where Leidos operates.
  • The vesting schedule of three years is also typical, aligning with industry norms for long-term incentive plans.
  • Comparing the size of the grant to similar roles at companies like Booz Allen Hamilton or General Dynamics would provide further context on its relative value.

Stakeholder Impact

  • The stock option grant could potentially impact shareholders by diluting equity if the options are exercised.
  • It incentivizes the Chief Growth Officer to drive company growth, which could benefit shareholders, employees, and other stakeholders.

Key Dates

DateDescription
03/08/2024Date of stock option grant and transaction.
03/08/2025First vesting date for the stock options (33 1/3%).
03/07/2031Expiration date of the stock options.
03/12/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.